Foradil, Formoterol
Foradil, Formoterol Newswire

Foradil, Formoterol Newswire

Comprehensive Real-Time News Feed for Foradil, Formoterol (generic).

Results 1 - 20 of 44 in Foradil, Formoterol (generic)

  1. Combination formoterol and budesonide as maintenance and reliever...Read the original story

    Saturday Aug 29 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Background Asthma is characterised by chronic inflammation of the airways and recurrent exacerbations with wheezing, chest tightness and cough.

    Comment?

  2. SkyePharma PLC Now Covered by Analysts at FinnCapRead the original story

    Saturday Aug 29 | AmericanBankingNews.com

    The brokerage set a "buy" rating and a GBX 351 price target on the stock. FinnCap's price target suggests a potential upside of 7.92% from the company's previous close.

    Comment?

  3. Tips From a Pro: An Introduction to Microscopic PhotographyRead the original story w/Photo

    Wednesday Aug 26 | Popular Photography

    This photomicrograph is of a snowflake photographed January 2, 2014. The ice crystal was approximately 1 mm in size.

    Comment?

  4. SkyePharma PLC Stock Rating Reaffirmed by N+1 SingerRead the original story

    Wednesday Aug 26 | AmericanBankingNews.com

    's stock had its "corporate" rating reaffirmed by research analysts at N+1 Singer in a research note issued to investors on Wednesday, Marketbeat reports. SKP has been the topic of several other reports.

    Comment?

  5. SkyePharma PLC Receives Buy Rating from Stifel NicolausRead the original story

    Monday Aug 24 | AmericanBankingNews.com

    's stock had its "buy" rating restated by equities researchers at Stifel Nicolaus in a research note issued to investors on Monday, Market Beat.com reports. They currently have a GBX 460 target price on the stock.

    Comment?

  6. Report Published: 'Mundipharma International Limited - Strategic SWOT Analysis Review'Read the original story

    May 24, 2013 | PR-inside.com

    Mundipharma International Limited is a biopharmaceutical company. It conducts research, develops, manufactures and commercializes drugs for pain management, cancer, rheumatoid arthritis and respiratory areas.

    Comment?

  7. Mundipharma International Limited - Pharmaceuticals & Healthcare - Deals and Alliances ProfileRead the original story

    Jul 22, 2015 | PR-inside.com

    Mundipharma International Limited is a biopharmaceutical company. It conducts research, develops, manufactures and commercializes drugs for pain management, cancer, rheumatoid arthritis and respiratory areas.

    Comment?

  8. Teva's DuoResp Spiromax Wins Leading Award For Medical Design ExcellenceRead the original story

    Jul 5, 2015 | BioSpace

    Teva Pharmaceutical Industries Ltd. today announced that its DuoResp SpiromaxA inhaler has won silver at the 2015 Medical Design Excellence Awards . The awards recognize significant advances in medical product design that improve the quality of healthcare delivery.

    Comment?

  9. Teva's DuoResp Spiromax Wins Leading Award For Medical Design ExcellenceRead the original story

    Jul 1, 2015 | BioSpace

    Teva Pharmaceutical Industries Ltd. today announced that its DuoResp SpiromaxA inhaler has won silver at the 2015 Medical Design Excellence Awards . The awards recognize significant advances in medical product design that improve the quality of healthcare delivery.

    Comment?

  10. Teva's DuoResp SpiromaxA Wins Leading Award for Medical Design ExcellenceRead the original story

    Jul 1, 2015 | Sys-Con Media

    Teva Pharmaceutical Industries Ltd. today announced that its DuoResp SpiromaxA inhaler has won silver at the 2015 Medical Design Excellence Awards . The awards recognize significant advances in medical product design that improve the quality of healthcare delivery.

    Comment?

  11. Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaRead the original story

    Jun 28, 2015 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Inhaled glucocorticoids are considered the first-line treatment for patients with moderate-to-severe, persistent asthma.1?3 However, many patients taking an inhaled glucocorticoid continue to have symptoms and need additional treatment.

    Comment?

  12. Test your medicine knowledge: 72-year-old woman with COPDRead the original story w/Photo

    Jun 27, 2015 | Kevin, M.D.

    A 72-year-old woman is evaluated during a routine examination. She has very severe COPD with multiple exacerbations.

    Comment?

  13. New Market Research Report: Chiesi Farmaceutici SpA - Pharmaceuticals ...Read the original story

    Jun 25, 2015 | PR-inside.com

    The company researches, develops and distributes pharmaceutical products with particular focus on respiratory, cardiovascular, and rare diseases. Its products include Atimos, Bramitob, Clenil, Curosurf, Foster, Iperten, and Peyona.

    Comment?

  14. Unsafe prescribing increases risk of life threatening asthma attacksRead the original story w/Photo

    Jun 18, 2015 | Medical News

    Last year's National Review of Asthma Deaths highlighted prescribing errors in nearly half of asthma deaths in primary care . Now new analysis from Asthma UK, based on data from over 500 UK GP practices, reveals evidence that over 22,000 people with asthma in the UK, including 2,000 children, have been prescribed medicines in a way that is so unsafe they have a 'black box warning' in the USA due to the risk they pose to the lives of people with asthma.

    Comment?

  15. Tens of thousands at risk in UK of potentially life threatening...Read the original story

    Jun 16, 2015 | Medical News Today

    Last year's National Review of Asthma Deaths1 highlighted prescribing errors in nearly half of asthma deaths in primary care . Now new analysis from Asthma UK, based on data from over 500 UK GP practices2, reveals evidence that over 22,000 people with asthma in the UK, including 2,000 children, have been prescribed medicines in a way that is so unsafe they have a 'black box warning' in the USA due to the risk they pose to the lives of people with asthma3.

    Comment?

  16. Thousands at risk from incorrect asthma inhaler prescriptionsRead the original story w/Photo

    Jun 16, 2015 | Halesowennews.co.uk

    TENS of thousands of people are at risk of potentially life-threatening asthma attacks because they are not being correctly prescribed inhalers, a charity has warned. Asthma UK said more than 22,000 people with asthma in the UK - including 2,000 children - have been incorrectly prescribed long-acting reliever inhalers.

    Comment?

  17. Thousands of people at risk of potentially life-threatening asthma...Read the original story w/Photo

    Jun 15, 2015 | IcNetwork

    More than 22,000 people with asthma, including 2,000 children, have been prescribed medicines in a way which could lead to fatal attacks Thousands of people could be at risk of suffering a deadly asthma attack from poor prescribing methods, says Asthma UK Tens of thousands of people are at risk of potentially life-threatening asthma attacks due to unsafe prescribing methods, a charity has warned. New analysis from Asthma UK found that more than 22,000 people with asthma in the UK have been prescribed "long-acting" reliever inhalers in a way that is so unsafe their treatment would be seen as dangerous in the United States.

    Comment?

  18. Thousands of asthma sufferers at risk as many inhalers 'not properly prescribed', says charityRead the original story w/Photo

    Jun 15, 2015 | Gazetteandherald.co.uk

    TENS of thousands of people are at risk of potentially life-threatening asthma attacks because they are not being correctly prescribed inhalers, a charity has warned. Asthma UK said more than 22,000 people with asthma in the UK - including 2,000 children - have been incorrectly prescribed long-acting reliever inhalers, which carry a black box warning in the United States because they are unsafe if not used appropriately.

    Comment?

  19. Asthma suffers used reliever inhalersRead the original story w/Photo

    Jun 15, 2015 | Chelmsfordweeklynews.co.uk

    Tens of thousands of people are at risk of potentially life-threatening asthma attacks because they are not being correctly prescribed inhalers, a charity has warned. Asthma UK said more than 22,000 people with asthma in the UK - including 2,000 children - have been incorrectly prescribed long-acting reliever inhalers, which carry a black box warning in the United States because they are unsafe if not used appropriately.

    Comment?

  20. Global market for asthma treatment expected to reach $21.7 billion by 2020Read the original story w/Photo

    May 29, 2015 | Medical News

    Despite generic erosion facing several of the leading asthma brands, such as Advair , Symbicort and Xolair , the global market for asthma treatment is set to witness moderate growth by the end of the decade. New analysis from business intelligence provider GBI Research Asthma Therapeutics Market to 2020 forecasts the asthma therapeutics market to grow marginally across the top eight developed nations, from $18.4 billion in 2013 to a projected value of $21.7 billion by 2020 at a Compound Annual Growth Rate of 2.4%.

    Comment?